JOFOC - Omnicell Upgrades_6.1.2026_Copy.docx

Justification for Other than Full and Open Competition (JOFOC)

RFO - FAR 6.103-1

1. Acquisition Title: Software/Hardware upgrade – Omnicell, 500 Cranberry Woods Drive Cranberry Township, PA 1600665224, Ph: 650-251-6155

Division: NIH Clinical Center, Pharmacy Department

Contracting Activity: DHHS, National Institutes of Health, Clinical Center

Author: Richard DeCederfelt, Service Chief, Pharmacy Business Management

Basis for approval under RFO - FAR 6.104(c): Health and Human Services Acquisition Regulation (HHSAR) Class Deviation 2024-01

2. Nature and/or Description of the Action being Approved:

The National Institutes of Health (NIH), Clinical Center (CC) Pharmacy Department requests a firm-fixed-price award for equipment and services related to upgrading the software, license, and hardware components to the Omnicell servers, automated dispensing cabinets, and anesthesia workstations. These upgrades also include a 12-month contract for maintenance and support of the Omnicell pharmacy management system.

The Government projects award for July 2026 using fiscal year 2026 Operations funds.

3. Description of Supplies and/or Services:

Equipment and software updates are required to bring the equipment into compliance with Win10 LTSC version to allow for ongoing security updates. The service agreement shall satisfy the standards of the Original Equipment Manufacturer (Omnicell, Inc.) and include, but are not limited to, replacement parts coverage, service support, telephone support, software and hardware support, support service, full maintenance coverage by providing all replacement parts, labor, travel expenses, tools, test equipment and other incidentals necessary to maintain or restore the listed equipment to operating specifications according to the manufacturer s recommendations.

4. Statutory Authority Cited and Rationale:

a. RFO - FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. Authority: 41 U.S.C. 3304(a)(1). Per RFO - HHSAR 306.103-1, for acquisitions covered by 42 U.S.C. 247d-6a(b)(2)(A), “available from only one responsible source” must be deemed to mean “available from only one responsible source or only from a limited number of responsible sources.”

This is a proprietary system, including all software and hardware. Omnicell, Inc is the Original Equipment Manufacturer and is the only known, authorized service provider for equipment and software upgrades, repair services, and preventative maintenance services on Omnicell equipment.

5. Special Considerations for Certain Contract Extensions or Bridge Contracts: N/A

6. Actions to Increase Competition:

a. A Notice Was Published:

7. Market Research:

Historical Purchases were investigated. Through trade shows, continuous learning seminars and trade journals, the CC Pharmacy Department stays abreast of the industry and is current on the availability of Pharmacy Medication Management Systems.

The Omnicell Automated Dispensing Cabinets and Pharmacy Medication Management System are government owned property and require service and maintenance by authorized, certified technicians to support continuity of operations for the Clinical Center, Pharmacy Department.

9. Additional Information or Other Facts: N/A

10. Technical or Requirements Program Management Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief.

Richard DeCederfelt Service Chief, Pharmacy Business Management

Signature & Date:

11. Fair and Reasonable Price Determination: As the contracting officer, I hereby determine that the anticipated price to the Government for this contract action will be fair and reasonable.

Select the applicable squares to mark the techniques used:

This determination will be made using the following: ☐ cost analysis ☐ price analysis ☐ cost realism ☒ market pricing ☐ historical pricing ☐ other: Describe the methodology or combination of methodologies that will be used. See RFO - FAR subpart 15.2 for proposal analysis guidance.

As a part of this basis, certified cost, or pricing data (see RFO - FAR 15.403)— ☐ will be required. ☒ will not be required and the following FAR part 15 exception applies:

☐ Prices that will be agreed upon are based on adequate price competition.

☐ Prices that will be agreed upon are based on prices set by law or regulation.

☒ A commercial item is being acquired.

☐ A waiver has been granted by the HCA in accordance with RFO - FAR 15.403-2(c)(4).

☐ The contract action is a modification to a contract or subcontract for commercial item(s).

☐ The estimated cost of the contract action is less than the threshold for certified cost or pricing data.

The price is determined to be fair and reasonable based on Federal Supply Schedule Pricing 36F79723D0073

12. Contracting Officer (CO) Certification and Determination: I hereby certify that this justification is accurate and complete to the best of my knowledge and belief. And, based upon the foregoing, I also determine that using a sole-source contract is in the best interest of (insert Division). [Always required; CO approval authority is limited to $900 thousand.]

Typed Name

(The following Reviews and Approvals will ordinarily be provided on a separate page at the end of the justification to allow for minor, administrative changes to be made during the review process; delete any individual reviews/approvals not applicable.)

ELEVATED REVIEWS & APPROVALS

13. Insert Division Division Director: I reviewed this justification find that it adequately supports other than full and open competition.

Typed Name

14. NIH Head of the Contracting Activity (HCA) Review and Approval: I reviewed this justification and find that it adequately supports other than full and open competition. [Division HCA approval authority is limited to $90 million.]

Typed Name

15. NIH Advocate for Competition (AfC) Review and Approval: I reviewed this justification find that it adequately supports other than full and open competition. [Division AfC approval authority is limited to $20 million.]

Typed Name

16. HHS Office of General Counsel Review and Concurrence: I reviewed this justification and concur that it adequately supports other than full and open competition. [Mandatory when SPE approval is required, unless otherwise waived in writing by the SPE.]

Typed Name

17. HHS Advocate for Competition (AfC) Review and Concurrence: I reviewed this justification and concur that it adequately supports other than full and open competition. [Mandatory when SPE approval is required.]

Typed Name

FINAL APPROVAL

18. HHS Senior Procurement Executive: Based on the foregoing, I hereby approve this justification for other than full and open competition pursuant to the authority of 41 U.S.C. 3304(a)(1) and in accordance with RFO - FAR 6.103. [Required if the total action value, including all options and FAR 52.217-8 value, exceeds $90 million.]

Typed Name

image1.emf image2.emf image3.emf image4.emf image5.emf